← Open Payments lookup

RICHARD BOWLING: Open Payments

NPI 1114007085 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,976 in 87 payments from 21 companies in 2025. Trend: 2023 $1,526 · 2024 $1,978 · 2025 $1,976

Food & beverage: $1,881Education: $65Long term medical supply or device loan: $30
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP15$335
Novo Nordisk Inc10$246
GlaxoSmithKline, LLC.9$213
Lilly USA, LLC8$187
PFIZER INC.7$169
Boehringer Ingelheim Pharmaceuticals, Inc.6$157
Intra-Sana Laboratories4$90
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$88
Phathom Pharmaceuticals, Inc.7$88
VERTEX PHARMACEUTICALS INCORPORATED4$87

Products named: MOUNJARO, TRELEGY ELLIPTA, AIRSUPRA, JARDIANCE, Ozempic, RELTONE 200 MG, CAPLYTA, VOQUEZNA.

Industry payments across CA — which companies pay providers there.